Method for the treatment of increased urinary urgency or urinary incontinence comprising administering (+)-tramadol, O-demethyltramadol, (+)-O-demethyltramadol, O-desmethyl-N-mono-desmethyltramadol, or (+)-O-desmethyl-N-mono-desmethyltramadol, as free bases and/or in the form of physiologically compatible salts, are disclosed.

Methode für die Behandlung der erhöhten urinausscheidenden Dringlichkeit oder des urinausscheidenden incontinence, die das Ausüben enthalten (+)-tramadol, O-demethyltramadol, (+)-O-demethyltramadol, O-desmethyl-Nmono-desmethyltramadol oder (+)-O-desmethyl-N-mono-desmethyltramadol, als freie Unterseiten und/oder in Form von physiologisch kompatiblen Salzen, werden freigegeben.

 
Web www.patentalert.com

< Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo [b] thiophene hydrochloride

< Benzotriazoles anti-inflammatory compounds

> Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)

> Process for the preparation of metaxalone

~ 00094